• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Geldanamycin

CAS No. 30562-34-6

Geldanamycin ( NSC 122750 )

产品货号. M13974 CAS No. 30562-34-6

Geldanamycin 是一种天然存在的 HSP90 抑制剂,Kd 为 1.2 μM,特异性破坏糖皮质激素受体 (GR)/HSP 关联。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥563 有现货
5MG ¥938 有现货
10MG ¥1549 有现货
25MG ¥2530 有现货
50MG ¥3525 有现货
100MG ¥4797 有现货
500MG 获取报价 有现货
1G 获取报价 有现货
1 mL x 10 mM in DMSO ¥1216 有现货

生物学信息

  • 产品名称
    Geldanamycin
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    Geldanamycin 是一种天然存在的 HSP90 抑制剂,Kd 为 1.2 μM,特异性破坏糖皮质激素受体 (GR)/HSP 关联。
  • 产品描述
    Geldanamycin is a natural existing HSP90 inhibitor with Kd of 1.2 μM, specifically disrupts glucocorticoid receptor (GR)/HSP association.(In Vitro):Geldanamycin significantly delays and reduces viperin expression, indicating that IRF3 is involved in viperin induction in RAW264.7 cells. Geldanamycin (GA), a benzoquinone ansamycin, protected against neuronal injury induced by oxygen-glucose deprivation (OGD)/zVAD treatment in cultured primary neurons. More importantly, Geldanamycin decreases RIP1 protein level in a time and concentration-dependent manner. Geldanamycin also decreases the Hsp90 protein level, which causes instability of RIP1 protein, resulting in decreased RIP1 protein level but not RIP1 mRNA level after Geldanamycin treatment. Geldanamycin (GA) is identified as the first natural product inhibitor of Hsp90 that binds to the N-terminal ATPase domain of Hsp90 to inhibit its chaperone function, and significantly induces tumor cell death via an apoptotic mechanism.
  • 体外实验
    ——
  • 体内实验
    ——
  • 同义词
    NSC 122750
  • 通路
    Cytoskeleton/Cell Adhesion Molecules
  • 靶点
    HSP
  • 受体
    HSP90| HSP90| p185
  • 研究领域
    Cancer
  • 适应症
    ——

化学信息

  • CAS Number
    30562-34-6
  • 分子量
    560.64
  • 分子式
    C29H40N2O9
  • 纯度
    >98% (HPLC)
  • 溶解度
    DMSO:50 mg/mL warmed (89.18 mM); Ethanol:<1 mg/mL (<1 mM); Water:<1 mg/mL (<1 mM)
  • SMILES
    NC(O[C@@H](/C(C)=C/[C@H](C)[C@@H](O)[C@@H](OC)C[C@H](C)CC1=C2OC)[C@@H](OC)/C=C\C=C(C)\C(NC(C1=O)=CC2=O)=O)=O
  • 化学全称
    (4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.Roe SM, et al, J Med Chem, 1999, 42(2), 260-266.
产品手册
关联产品
  • PU-H71 HCl

    PU-H71 HCl (Zelavespib HCl) is a novel Hsp90 inhibitor, a novel purine-based analog, and a radiosensitizer that may be a promising agent for CIRT. PU-H71 HCL shows antitumor activity in many preclinical models of malignancy. PU-H71 HCL has an inhibitory effect on the protein expression levels of Rad51 and Ku70, which may be associated with the double chain break repair in the homologous recombination pathway and non-homologous end-joining pathway.

  • NSC 145366

    NSC 145366 是一种新型变构 Hsp90 CTD(C 末端结构域)抑制剂。

  • KU-32

    一种基于新生霉素的新型 Hsp90 C 末端抑制剂和 Hsp70 的有效诱导剂。